Efficacy of rociletinib (CO-1686) in plasma-genotyped T790M-positive non-small cell lung cancer (NSCLC) patients (pts) Meeting Abstract

  

Authors:	Sequist, L. V.; Goldman, J. W.; Wakelee, H. A.; Camidge, D. R.; Yu, H. A.; Varga, A.; Solomon, B.; Oxnard, G. R.; Ou, S. H. I.; Papadimitrakopoulou, V.; Chao, B. H.; Liu, S. V.; Reckamp, K. L.; Spira, A. I.; Piotrowska, Z.; Despain, D.; Karlovich, C. A.; Yurasov, S.; Soria, J. C.
Abstract Title:	Efficacy of rociletinib (CO-1686) in plasma-genotyped T790M-positive non-small cell lung cancer (NSCLC) patients (pts)
Meeting Title:	51st Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	33
Issue:	15 Suppl.
Meeting Dates:	2015 May 29-Jun 2
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2015-05-20
Language:	English
ACCESSION:	WOS:000358036901714
PROVIDER:	wos
DOI:	10.1200/JCO.2015.33.15_suppl.8001
Notes:	Meeting Abstract: 8001 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/80583